0001171843-18-003058.txt : 20180425
0001171843-18-003058.hdr.sgml : 20180425
20180425165829
ACCESSION NUMBER: 0001171843-18-003058
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180425
FILED AS OF DATE: 20180425
DATE AS OF CHANGE: 20180425
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Katz Richard D
CENTRAL INDEX KEY: 0001293577
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35443
FILM NUMBER: 18775009
MAIL ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 300
CITY: DURHAM
STATE: NC
ZIP: 27703
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARGOS THERAPEUTICS INC
CENTRAL INDEX KEY: 0001105533
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 562110007
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4233 TECHNOLOGY DR
CITY: DURHAM
STATE: NC
ZIP: 27704
BUSINESS PHONE: 9192876300
MAIL ADDRESS:
STREET 1: 4233 TECHNOLOGY DR
CITY: DURHAM
STATE: NC
ZIP: 27704
FORMER COMPANY:
FORMER CONFORMED NAME: MERIX BIOSCIENCE INC
DATE OF NAME CHANGE: 20000207
4
1
formfour.xml
OWNERSHIP DOCUMENT
X0306
4
2018-04-25
0
0001105533
ARGOS THERAPEUTICS INC
ARGS
0001293577
Katz Richard D
4505 EMPEROR BOULEVARD, SUITE 300
DURHAM
NC
27703
0
1
0
0
Vice President and CFO
Common Stock
2018-04-25
4
D
0
22629
0
D
9697
D
Represents shares forfeited upon the delisting of the Company's common stock from The Nasdaq Capital Market.
/s/ Lori R. Harrelson, attorney in fact
2018-04-25